Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Needle-Free Jet Injection vs Needle and Syringe for Influenza Vaccine
NCT02290691Phase 4Completed
- Sponsor
- PharmaJet
- Start
- Nov 2014
- Primary completion
- Jan 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of influenza vaccine in influenza (2 arms), sponsored by PharmaJet. Primary endpoints: Anti Influenza Hemagglutination Inhibition Antibody Geometric Mean Titers at 28 days and Number of Participants Achieving Seroconversion or Significant Increase in Antibody Titer at 28 days. Started Nov 2014; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02290691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02290691.